Sulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Oil Serum

Manufacturer
J. Strickland and Co.
Effective date
2023-10-21
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 23:57:07

Label at a glance#

ProductSulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Oil Serum
Active ingredientSULFUR
Label structure6 sections

Dosage and administration

Shake well before using. For best results, use at least twice a week, or as directed by a doctor. Before shampooing your hair, apply a small amount to the scalp in several areas. Rub in well. Wait 15 minutes. Shampoo thoroughly.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Sulfur, 2.5%

Purpose

OTC - PURPOSE SECTION

Antidandruff

Use

INDICATIONS & USAGE SECTION

Controls scalp itching an flaking due to dandruff

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

avoid contact with eyes. If contact occurs rinse eyes thoroughly with water.

Stop use and consult a doctor if

OTC - STOP USE SECTION

  • if skin irritation develops or increases.
  • condition worsens or does not improve after regular use as directed.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or call a Poison Control Center at once.

Flammability is increased by proudct build-up. Keep hair away from sparks, flame, extreme heat or lit tobacco. Hair is Flammable.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Shake well before using.
  • For best results, use at least twice a week, or as directed by a doctor.
  • Before shampooing your hair, apply a small amount to the scalp in several areas. Rub in well. Wait 15 minutes. Shampoo thoroughly.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Mineral Oil (Paraffinum Liquidum), Polysorbate 85, Disteardimonium Hectorite, Propylene Glycol, Benzyl Alcohol, Fragrance (Parfum)

Package Labeling:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Outer Package2Outer Package2Inner Package2Inner Package2

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
247683sulfur 2.5 % Medicated ShampooPSN3
247683sulfur 25 MG/ML Medicated ShampooSCD3
247683sulfur 2.5 % Medicated ShampooSY3

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
12022-034-00Sulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Oil Serum81 mL in 1 BOTTLESUSPENSION813
12022-034-00Sulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Oil Serum1 in 1 BOXSUSPENSION13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
12022-034SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL SCALP OIL SERUM (SULFUR) SUSPENSION [J. STRICKLAND AND CO.]3Current NDC, Legacy NDC, 2 package rows20231021_96b249a2-3f50-1ab8-e053-2995a90a56ed.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
12022-03412022-034-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sulfur 8 Scalp Therapy Medicated Dandruff Control Scalp Oil SerumSULFURJ. Strickland and Co.96b249a2-3f50-1ab8-e053-2995a90a56ed2023-10-21WarningsExact identifier
ndc (package): 12022-034-00
ndc (product): 12022-034
ndc11 (package): 12022003400
spl id: 0834f4b7-cae4-182f-e063-6294a90a7faa
spl set id: 96b249a2-3f50-1ab8-e053-2995a90a56ed

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.